Company / Current Liabilities per Share
Phathom Pharmaceuticals, Inc. Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.93
FY2025
5-year range
$0.51 / $1.93
FY2021-FY2025
Trend
+30.3%
vs FY2024
Sector context
#70 of 210
Health Care
What the data says
At $1.93, Phathom Pharmaceuticals, Inc.'s current liabilities per share ranks #141 of 210 in the Health Care sector. Current Liabilities per Share has increased for 4 consecutive years, from $0.51 in FY2021 to $1.93 in FY2025.
Based on SEC 10-K filings.
1.93 in FY2025 with a 5-year CAGR of +2.9%.
Increased from $0.94 to $1.93 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +42.2%
- 5-Year CAGR
- +2.9%
- 10-Year CAGR
- -
Sector benchmark
#141 of 210 in Health CareTop 67% of 210This company $1.93 Sector average $15.78
▼
-87.8% below sector average
Key checks
Key Insights
- Phathom Pharmaceuticals, Inc.'s current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 30.3% year-over-year.
- Ranks #70 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.93 | +30.3% |
| FY2024 | $1.48 | +58.1% |
| FY2023 | $0.94 | +39.4% |
| FY2022 | $0.67 | +31.2% |
| FY2021 | $0.51 | -69.4% |
| FY2020 | $1.67 | +406.8% |
| FY2019 | $0.33 | -8.8% |
| FY2018 | $0.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026